Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Child

Showing results (201-210 of 252) with videos related to

Pageof 26
Sort By:
Clinical and Experimental Pharmacology & Physiology|July 1, 1984
Effect of antihypertensive drugs on neonatal blood pressureD J Henderson-Smart, J S Horvath, A Phippard, et al.
British Journal of Haematology|February 13, 2001
Interleukin 6, tumour necrosis factor alpha and lymphotoxin alpha polymorphisms in monoclonal gammopathy of uncertain significance and multiple myelomaA M Dring, F E Davies, S J Rollinson, et al.
Biochemical Society Transactions|May 30, 2003
Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndromeN J A Child, I A Yang, M C K Pulletz, et al.
American Journal of Clinical Pathology|September 14, 2001
Waldenström macroglobulinemia. Development of diagnostic criteria and identification of prognostic factorsR G Owen, S L Barrans, S J Richards, et al.
American Journal of Human Genetics|September 1, 1991
Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the geneK Kainulainen, B Steinmann, F Collins, et al.
Hematological Oncology|July 1, 1991
Twin-track studies of ifosfamide and mitoxantrone (I-M) in recurrent high grade non-Hodgkin's lymphoma and Hodgkin's disease. Yorkshire Regional Lymphoma and Central Lymphoma GroupsJ A Child, A V Simmons, D L Barnard, et al.
Leukemia & Lymphoma|April 7, 2000
FLUDAP: salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphomaJ A Child, S A Johnson, S Rule, et al.
Hematological Oncology|July 1, 1990
Ifosfamide and mitoxantrone (I-M) in relapsed and refractory high grade non-Hodgkin's lymphoma and Hodgkin's diseaseG J Dovey, J A Child, A V Simmons, et al.
Hematological Oncology|March 5, 1999
Liposomal daunorubicin: in vitro and in vivo efficacy in multiple myelomaG Pratt, M E Wiles, A C Rawstron, et al.
Journal of Medical Genetics|December 24, 1998
Novel TIGR/MYOC mutations in families with juvenile onset primary open angle glaucomaD Stoilova, A Child, G Brice, et al.
Pageof 26

Showing results (201-210 of 252) with videos related to

Sort By:
Pageof 26
Clinical and Experimental Pharmacology & Physiology|July 1, 1984
Effect of antihypertensive drugs on neonatal blood pressureD J Henderson-Smart, J S Horvath, A Phippard, et al.
British Journal of Haematology|February 13, 2001
Interleukin 6, tumour necrosis factor alpha and lymphotoxin alpha polymorphisms in monoclonal gammopathy of uncertain significance and multiple myelomaA M Dring, F E Davies, S J Rollinson, et al.
Biochemical Society Transactions|May 30, 2003
Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndromeN J A Child, I A Yang, M C K Pulletz, et al.
American Journal of Clinical Pathology|September 14, 2001
Waldenström macroglobulinemia. Development of diagnostic criteria and identification of prognostic factorsR G Owen, S L Barrans, S J Richards, et al.
American Journal of Human Genetics|September 1, 1991
Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the geneK Kainulainen, B Steinmann, F Collins, et al.
Hematological Oncology|July 1, 1991
Twin-track studies of ifosfamide and mitoxantrone (I-M) in recurrent high grade non-Hodgkin's lymphoma and Hodgkin's disease. Yorkshire Regional Lymphoma and Central Lymphoma GroupsJ A Child, A V Simmons, D L Barnard, et al.
Leukemia & Lymphoma|April 7, 2000
FLUDAP: salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphomaJ A Child, S A Johnson, S Rule, et al.
Hematological Oncology|July 1, 1990
Ifosfamide and mitoxantrone (I-M) in relapsed and refractory high grade non-Hodgkin's lymphoma and Hodgkin's diseaseG J Dovey, J A Child, A V Simmons, et al.
Hematological Oncology|March 5, 1999
Liposomal daunorubicin: in vitro and in vivo efficacy in multiple myelomaG Pratt, M E Wiles, A C Rawstron, et al.
Journal of Medical Genetics|December 24, 1998
Novel TIGR/MYOC mutations in families with juvenile onset primary open angle glaucomaD Stoilova, A Child, G Brice, et al.
Pageof 26